MEDBOT-B shares surge 6% on first half-year profit fueled by surgical robot revenue growth

Stock News08-04

MEDBOT-B (02252) shares jumped over 6% in early trading, last changing hands at HK$22.60, with turnover reaching HK$101 million. The stock is up 6.3% at the time of writing.

On the news front, the company recently issued a profit alert, expecting a net profit of between 28 million yuan and 40 million yuan for the first half of the year, compared to a loss of 115 million yuan in the same period last year. This marks the company's first half-yearly profit. Revenue is expected to rise by approximately 200% to 230%, calculated to be between 527 million yuan and 580 million yuan. The company's key product, the Toumai surgical robot, saw overseas revenue increase by more than 450%, while the overall gross margin improved by over 15 percentage points.

Public information shows that MEDBOT-B's flagship systems, including Toumai and Honghu, have received market approval in regions such as China and the European Union. In a research note, UOB Kay Hian stated that MEDBOT-B is pioneering the development of 5G-powered remote surgery and integrating AI functions to enhance surgical precision and outcomes. Leveraging the extensive global network of its parent company, MicroPort Scientific, the company has entered over 60 countries, posing a challenge to major international competitors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1104166463?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-04 11:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104166463","market":"sg","top_or_hot":-1,"title":"MEDBOT-B shares surge 6% on first half-year profit fueled by surgical robot revenue growth","media":"Stock News","content":"<p><b>MEDBOT-B</b> (02252) shares jumped over 6% in early trading, last changing hands at HK$22.60, with turnover reaching HK$101 million. The stock is up 6.3% at the time of writing.<br><br>On the news front, the company recently issued a profit alert, expecting a net profit of between 28 million yuan and 40 million yuan for the first half of the year, compared to a loss of 115 million yuan in the same period last year. This marks the company's first half-yearly profit. Revenue is expected to rise by approximately 200% to 230%, calculated to be between 527 million yuan and 580 million yuan. The company's key product, the Toumai surgical robot, saw overseas revenue increase by more than 450%, while the overall gross margin improved by over 15 percentage points.<br><br>Public information shows that <b>MEDBOT-B</b>'s flagship systems, including Toumai and Honghu, have received market approval in regions such as China and the European Union. In a research note, UOB Kay Hian stated that <b>MEDBOT-B</b> is pioneering the development of 5G-powered remote surgery and integrating AI functions to enhance surgical precision and outcomes. Leveraging the extensive global network of its parent company, MicroPort Scientific, the company has entered over 60 countries, posing a challenge to major international competitors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEDBOT-B shares surge 6% on first half-year profit fueled by surgical robot revenue growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEDBOT-B shares surge 6% on first half-year profit fueled by surgical robot revenue growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-04 11:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>MEDBOT-B</b> (02252) shares jumped over 6% in early trading, last changing hands at HK$22.60, with turnover reaching HK$101 million. The stock is up 6.3% at the time of writing.<br><br>On the news front, the company recently issued a profit alert, expecting a net profit of between 28 million yuan and 40 million yuan for the first half of the year, compared to a loss of 115 million yuan in the same period last year. This marks the company's first half-yearly profit. Revenue is expected to rise by approximately 200% to 230%, calculated to be between 527 million yuan and 580 million yuan. The company's key product, the Toumai surgical robot, saw overseas revenue increase by more than 450%, while the overall gross margin improved by over 15 percentage points.<br><br>Public information shows that <b>MEDBOT-B</b>'s flagship systems, including Toumai and Honghu, have received market approval in regions such as China and the European Union. In a research note, UOB Kay Hian stated that <b>MEDBOT-B</b> is pioneering the development of 5G-powered remote surgery and integrating AI functions to enhance surgical precision and outcomes. Leveraging the extensive global network of its parent company, MicroPort Scientific, the company has entered over 60 countries, posing a challenge to major international competitors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PBOT","symbol_name":"Pictet AI & Automation ETF","start_time":0,"source_url":"","article_id":"1104166463","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104166463","pubTimestamp":1785813623,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"MEDBOT-B (02252) shares jumped over 6% in early trading, last changing hands at HK$22.60, with turnover reaching HK$101 million. The stock is up 6.3% at the time of writing.On the news front, the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PBOT":"Pictet AI & Automation ETF","KOMP":"SPDR S&P Kensho New Economies Composite ETF","KCAI":"KraneShares China Alpha Index ETF","BK1617":"AI医疗","02252":"微创机器人-B","BK4588":"碎股","BK1100":"医疗保健设备","BK4585":"ETF&股票定投概念","ROBO":"全球机器人自动化ETF-ROBO","VXUS":"国际股票ETF-Vanguard"},"translate_title":"手术机器人收入增长推动上半年利润飙升 6%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ROBO":1,"KOMP":1,"KCAI":1,"PBOT":1,"02252":1,"VXUS":1},"content_text":"MEDBOT-B (02252) shares jumped over 6% in early trading, last changing hands at HK$22.60, with turnover reaching HK$101 million. The stock is up 6.3% at the time of writing.On the news front, the company recently issued a profit alert, expecting a net profit of between 28 million yuan and 40 million yuan for the first half of the year, compared to a loss of 115 million yuan in the same period last year. This marks the company's first half-yearly profit. Revenue is expected to rise by approximately 200% to 230%, calculated to be between 527 million yuan and 580 million yuan. The company's key product, the Toumai surgical robot, saw overseas revenue increase by more than 450%, while the overall gross margin improved by over 15 percentage points.Public information shows that MEDBOT-B's flagship systems, including Toumai and Honghu, have received market approval in regions such as China and the European Union. In a research note, UOB Kay Hian stated that MEDBOT-B is pioneering the development of 5G-powered remote surgery and integrating AI functions to enhance surgical precision and outcomes. Leveraging the extensive global network of its parent company, MicroPort Scientific, the company has entered over 60 countries, posing a challenge to major international competitors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104166463","isCrawlerRequest":true}